Baxter International Inc. reported its financial results for the third quarter of 2026, which ended September 30, 2026. The company announced that worldwide sales for the quarter totaled approximately $2.98 billion, representing an increase of 5% on both a reported and organic basis. This growth was attributed to performance across all segments and divisions globally.
On a U.S. Generally Accepted Accounting Principles (GAAP) basis, the company reported diluted earnings per share (EPS) of $0.57. Adjusted diluted EPS was reported at $0.58. Free cash flow for the third quarter was $448 million, with year-to-date free cash flow totaling $705 million.
Baxter International also provided an updated outlook for the full year of 2026. The company raised its guidance for reported sales growth from continuing operations to a range of 4% to 5%, up from the previously forecasted 3% to 4%. Organic sales growth from continuing operations is now expected to be between 3% and 4%, compared to the prior range of 2% to 3%. Adjusted earnings from continuing operations per diluted share are expected to be between $2.05 and $2.15.
In other corporate developments, the company’s Board of Directors declared a quarterly cash dividend of $0.01 per share of common stock. This dividend is payable on January 4, 2027, to stockholders of record as of November 27, 2026.
